iBio, Inc.
IBIO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -50% | – | -100% | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | -189% | 100% | – | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -5,395% | -2,417% | – | -2,013% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -5,720% | -2,581.5% | – | -2,182% |
| EPS Diluted | -0.11 | -0.31 | -0.49 | -0.48 |
| % Growth | 64.5% | 36.7% | -2.1% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |